Trade I think April and beyond will get more and more interesting.
This isn't the normal circumstance, this is the changing of a science...
Some will lose, some will win, but both will fight for their advantage. And I think we are seeing that a little play out now.
But if it is the case, that GERN should become the preferred treatment, then that could be quite valuable...
...as a start, where it can go after that, no body knows...